Cerner (NASDAQ:CERN) had its price objective lowered by SunTrust Banks from $79.00 to $66.00 in a report issued on Thursday, The Fly reports. The brokerage presently has a “buy” rating on the stock. SunTrust Banks’ price objective points to a potential upside of 10.81% from the stock’s previous close.

Other equities research analysts have also issued research reports about the stock. Canaccord Genuity boosted their price target on shares of Cerner from $80.00 to $81.00 and gave the company a “buy” rating in a report on Wednesday, February 5th. Stifel Nicolaus cut their price objective on shares of Cerner from to in a research report on Wednesday, March 11th. JPMorgan Chase & Co. cut their price objective on shares of Cerner from $75.00 to $74.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Cfra lifted their price objective on shares of Cerner from $72.00 to $76.00 and gave the stock a “hold” rating in a research report on Wednesday, February 5th. Finally, Wells Fargo & Co lifted their price objective on shares of Cerner from $80.00 to $83.50 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $77.64.

Shares of Cerner stock traded up $1.52 during trading on Thursday, hitting $59.56. The stock had a trading volume of 26,020 shares, compared to its average volume of 3,915,976. The firm’s fifty day simple moving average is $70.90 and its 200-day simple moving average is $70.34. The stock has a market cap of $18.10 billion, a PE ratio of 36.10, a PEG ratio of 1.51 and a beta of 0.89. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.04 and a quick ratio of 2.02. Cerner has a 12 month low of $53.08 and a 12 month high of $80.90.

Cerner (NASDAQ:CERN) last released its earnings results on Tuesday, February 4th. The company reported $0.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.74 by $0.01. Cerner had a net margin of 9.30% and a return on equity of 16.66%. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business earned $0.63 EPS. The business’s revenue was up 5.6% on a year-over-year basis. Analysts expect that Cerner will post 2.87 earnings per share for the current fiscal year.

In other news, CAO Michael R. Battaglioli sold 10,000 shares of the company’s stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $79.40, for a total value of $794,000.00. Following the sale, the chief accounting officer now directly owns 8,726 shares of the company’s stock, valued at approximately $692,844.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Randy D. Sims sold 188,780 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $80.00, for a total transaction of $15,102,400.00. The disclosure for this sale can be found here. Insiders sold a total of 392,180 shares of company stock worth $31,200,356 over the last ninety days. Insiders own 0.75% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. S.A. Mason LLC acquired a new position in shares of Cerner during the 4th quarter worth $29,000. NWK Group Inc. acquired a new position in shares of Cerner during the 4th quarter worth $33,000. Security National Trust Co. acquired a new position in shares of Cerner during the 4th quarter worth $34,000. Barnett & Company Inc. raised its stake in shares of Cerner by 429.2% during the 4th quarter. Barnett & Company Inc. now owns 471 shares of the company’s stock worth $35,000 after buying an additional 382 shares during the last quarter. Finally, Duncker Streett & Co. Inc. acquired a new position in shares of Cerner during the 4th quarter worth $44,000. Hedge funds and other institutional investors own 81.69% of the company’s stock.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Further Reading: How are Outstanding Shares Different from Authorized Shares?

The Fly

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.